<- Go Home
EssilorLuxottica Société anonyme
EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific. It offers lens, eyewear, contact lenses, reading glasses under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, iWear, Humanware, Optifog, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native Eyewear and Bolon, and Foster Grant brands. The company also provides vision assessment, eye pathology diagnosis and treatment, finishing equipment, fitting parameter measurement, small tools, and consumables. In addition, it offers SPECTRALIS, a multimodal imaging platform for the diagnosis and treatment; ANTERION, a multi-disciplinary all-in-one anterior segment imaging solution for measurements; HEYEX 2, an image management and device integration platform; HEYEX EMR, an electronic medical record platform; digital surgical visualization platform; and high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. Further, the company designs, develops, markets, and maintains lens edging and mounting instruments for opticians and prescription laboratories; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It sells its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and consumers through the network of brick and mortar retail network and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.
Market Cap
EUR 119.6B
Volume
529.9K
Cash and Equivalents
EUR 3.5B
EBITDA
EUR 6.6B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
EUR 17.0B
Profit Margin
59.74%
52 Week High
EUR 323.80
52 Week Low
EUR 225.90
Dividend
1.55%
Price / Book Value
3.08
Price / Earnings
51.87
Price / Tangible Book Value
-63.74
Enterprise Value
EUR 131.1B
Enterprise Value / EBITDA
19.92
Operating Income
EUR 3.5B
Return on Equity
6.07%
Return on Assets
3.38
Cash and Short Term Investments
EUR 3.5B
Debt
EUR 14.4B
Equity
EUR 39.5B
Revenue
EUR 28.5B
Unlevered FCF
EUR 3.4B
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium